Search results

Collaboration investigates a promising new nanoparticle for potential use in combination with other therapies for brain cancer

The new facility will be built around a product line of ANSTO’s design – a new Technetium-99m generator – that will enable greater process automation than is possible with existing technology, leading to improvements in efficiency, quality and importantly the highest levels of production safety.

The Medium Energy- X-ray Absorption Spectroscopy beamlines provides access to XANES and EXAFS data from a bending magnet source, optimised for cutting-edge applications in biological, agricultural and environmental science in an energy range that is not currently available at the Australia Synchrotron.

ANSTO has secured a $1.62 million Medical Research Future Fund (MRFF) grant under the Australian Brain Cancer Mission’s 2024 Brain Cancer Discovery and Translation program, administered by the Department of Health and Aged Care.  

ANSTO is a unique national science organisation that began operating under its predecessor The Australian Atomic Energy Commission (AAEC) 70 years ago.

Outstanding individuals and teams have been recognised for their outstanding work, innovation, excellence in the 2025 ANSTO Awards. 

Director of the Australian Synchrotron Prof Andrew Peele has been appointed to Australian Mathematical Sciences Board.